...
首页> 外文期刊>Journal of Krishna Institute of Medical Sciences University. >Tigecycline Susceptibility of Carbapenem Resistant Enterobacteriaceae and Acinetobacter spp . isolates from Respiratory Tract: A Tertiary Care Centre Study.
【24h】

Tigecycline Susceptibility of Carbapenem Resistant Enterobacteriaceae and Acinetobacter spp . isolates from Respiratory Tract: A Tertiary Care Centre Study.

机译:碳青霉素抗生素和分枝杆菌的替代氯丁易感性。呼吸道分离株:第三节护理中心研究。

获取原文

摘要

Background: Tigecycline is used as a last line of defence against Multidrug Resistant (MDR) strains, and increasing rates of resistance are a growing concern globally. Tigecycline resistance has been reported in various pathogens including Acinetobacter spp., Klebsiella spp., Enterobacter spp., E. faecalis, S. aureus, S. pneumoniae and Serratia marcescens. Aim and Objectives: To study Tigecycline susceptibility pattern of isolates of Enterobacteriaceae and Acinetobacter spp. from Respiratory Tract Infections (RTI) in a tertiary care hospital. Material and Methods: A total of 7573 respiratory samples were received in Microbiology Department of Govind Ballabh Pant Institute of Postgraduate Medical Education and Research (GIPMER) from 1st January 2018 to 31st December 2018. The samples were processed as per standard techniques. Identification and antimicrobial susceptibility testing was done by VITEK-2 Compact automated system and Kirby – Bauer Disc Diffusion Method as per CLSI Guidelines. Results: Out of total 7573 respiratory samples received in laboratory, 1017 (13.42%) were culture positive for pathogens. Klebsiella pneumoniae 420(41.29%) was predominantly isolated microorganism followed by Pseudomonas aeruginosa 206(20.25%) and Acinetobacter spp. 193(18.97%). Most of Gram negative organisms were resistant to commonly used antibiotics. Carbapenem resistance was observed as 67.25%. Conclusion: Overall Tigecycline resistance among Carbapenem Resistant Enterobacteriaceae (CRE) and Carbapenem Resistant Acinetobacter (CRA) was found to be 15.50% and 10.69% respectively. Although Tigecycline is a promising antibiotic for the treatment of infections caused by drug resistant problematic pathogens, Tigecycline resistance is most frequently observed in A. baumannii and Enterobacteriaceae, especially in MDR strains. Hence, we advocate judicious use of Tigecycline in MDR infections and it should be kept as reserve.
机译:背景:Tigecycline被用作针对多药抗性(MDR)菌株的最后一系列防御,并且抵抗率的增加是全球日益增长的关注。在各种病原体中报告了脱癸酸含量抗性,包括血管杆菌,肠杆菌,肠杆菌,肠杆菌,粪群岛,金黄色葡萄球菌,S.肺炎和塞拉特氏菌。瞄准和目标:研究肠杆菌和分子杆菌分离株的Tigeccline易感模式。从高等教育医院中呼吸道感染(RTI)。材料和方法:从2018年1月1日至2018年12月31日,在Govind Ballabh Pant Research of Prodgrade医学教育和研究(Gipmer)中的微生物学系中收到了7573次呼吸样品。按照标准技术处理样品。根据CLSI指南,Vitek-2紧凑型自动化系统和Kirby-Bauer椎间盘扩散方法进行鉴定和抗微生物敏感性测试。结果:在实验室中收到的7573个呼吸样品中,1017(13.42%)是病原体阳性的。 Klebsiella Pneumoniae 420(41.29%)主要是孤立的微生物,其次是假单胞菌铜绿假单胞菌206(20.25%)和分枝杆菌。 193(18.97%)。大多数革兰阴性有机体对常用的抗生素具有抗性。鲤鱼抗性被观察为67.25%。结论:发现含有肠道肠杆菌(CRE)和鲤鱼蛋白抗性抗菌(CRA)的总体氯丁含量分别为15.50%和10.69%。虽然Tigecycline是治疗因耐药病原体引起的感染的有前途的抗生素,但在A.Baumannii和肠杆菌痤疮中,替代霉素抗性最常观察到,特别是在MDR菌株中。因此,我们提倡在MDR感染中的明智使用Tigecycline,并且应该保留。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号